Company intelligence / Profile preview

MSM Medical

Waltham, Massachusetts, United States

Ownership: Private
Employees: ~3
Development stage: Other

Overview

MSM has successfully completed a dozen projects generating functional human antibodies to GPCRs in collaborative projects and for internal pipeline[1]

Therapeutic areas: HematologyImmunologyNeurologyDermatologyInfectious DiseasesPulmonologyOncology
Modalities: Antibody
Industry: Biotech

Drug pipeline

1 asset

MSM-605

Preclinical

Partnerships

Collaborative partnerships with Big Pharma companies in drug discovery and development programs[5]

Beyond the preview

Go deeper on MSM Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSM Medical.

Explore the full profile